Sumagan, Baby Boy .
HRN: 27-01-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/20/2025
04/27/2025
IV
42mg
Q24
T/C MAS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes